Další formáty:
BibTeX
LaTeX
RIS
@inproceedings{488056, author = {Skrickova, Jana and Babickova, Lenka and Kaplanová, Jana and Kubová, Olga and Pálková, Ivana and Tomísková, Marcela}, address = {Madrid, Spain}, booktitle = {Woorkbook of Iressa Clinical Experience Meeting}, keywords = {non-small-cell lung cancer; gefitinib treatment; antitumour activity;}, language = {cze}, location = {Madrid, Spain}, pages = {81-81}, publisher = {AstraZeneca}, title = {Second-line treatment with gefitinib (Iressa, ZD 1839) in patient with advanced non-small-cell lung cancer.}, year = {2003} }
TY - JOUR ID - 488056 AU - Skrickova, Jana - Babickova, Lenka - Kaplanová, Jana - Kubová, Olga - Pálková, Ivana - Tomísková, Marcela PY - 2003 TI - Second-line treatment with gefitinib (Iressa, ZD 1839) in patient with advanced non-small-cell lung cancer. PB - AstraZeneca CY - Madrid, Spain KW - non-small-cell lung cancer KW - gefitinib treatment KW - antitumour activity; N2 - A case is presented of a 73-year old female non-smoker with advanced, symptomatic NSCLC, initially treated with gemcitabine and carboplatin, but improved only after oral gefitinib 250mg/day, which was well tolerated and demonstrated good antitumour activity. ER -
SKRICKOVA, Jana, Lenka BABICKOVA, Jana KAPLANOVÁ, Olga KUBOVÁ, Ivana PÁLKOVÁ a Marcela TOMÍSKOVÁ. Second-line treatment with gefitinib (Iressa, ZD 1839) in patient with advanced non-small-cell lung cancer. In \textit{Woorkbook of Iressa Clinical Experience Meeting}. Madrid, Spain: AstraZeneca, 2003, s.~81.
|